LFGVX | VIGAX | LFGVX / VIGAX | |
Total Expense Ratio | 0.70 | 0.05 | 1,400% |
Annual Report Gross Expense Ratio | 1.10 | 0.05 | 2,200% |
Fund Existence | 7 years | 25 years | - |
Gain YTD | 17.807 | 16.121 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 165M | 328B | 0% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 38.25 | 23.97 | 160% |
Returns for 3 years | 123.23 | 117.59 | 105% |
Returns for 5 years | 61.31 | 113.97 | 54% |
Returns for 10 years | N/A | 387.40 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 154.80 | 2.69 | +1.77% |
Franklin Biotechnology Discovery R6 | |||
ILVBX | 10.96 | 0.14 | +1.29% |
Columbia Integrated Large Cap Val A | |||
JDERX | 12.41 | 0.12 | +0.98% |
PGIM Jennison Mid-Cap Growth R | |||
HBLCX | 14.67 | 0.05 | +0.36% |
Hartford Balanced Income C | |||
TLGAX | 14.26 | 0.04 | +0.28% |
Timothy Plan Large/Mid Cap Growth A |